Mechanism of action of hydroxyurea - PubMed (original) (raw)
Review
. 1992 Jun;19(3 Suppl 9):1-10.
Affiliations
- PMID: 1641648
Review
Mechanism of action of hydroxyurea
J W Yarbro. Semin Oncol. 1992 Jun.
Abstract
Hydroxyurea is well absorbed after oral administration, converted to a free radical nitroxide in vivo, and transported by diffusion into cells where it quenches the tyrosyl free radical at the active site of the M2 protein subunit of ribonucleotide reductase, inactivating the enzyme. The entire replitase complex, including ribonucleotide reductase, is inactivated and DNA synthesis is selectively inhibited, producing cell death in S phase and synchronization of the fraction of cells that survive. Repair of DNA damaged by chemicals or irradiation is also inhibited by hydroxyurea, offering potential synergy between hydroxyurea and radiation or alkylating agents. Hydroxyurea renders cells sensitive to bleomycin because the quenched tyrosyl free radical no longer stabilizes the adjacent iron center, making it more susceptible to the chelating properties of bleomycin, which then produces active oxygen. Synergy has also been observed between hydroxyurea and a number of other chemotherapeutic agents, including cytarabine and etoposide. Recently, two new effects of hydroxyurea have been observed: hydroxyurea increases the level of fetal hemoglobin, leading to a reduction in the incidence of vasoocclusive crises in sickle cell anemia, and hydroxyurea selectively reduces the level of episomal DNA and thus potentially may reduce drug resistance associated with duplicated genes retained as episomes. Further exploration of the efficacy of hydroxyurea in combination with other therapeutic agents is warranted.
Similar articles
- Hydroxyurea-induced conversion of mammalian ribonucleotide reductase to a form hypersensitive to bleomycin.
McClarty GA, Chan AK, Wright JA. McClarty GA, et al. Cancer Res. 1986 Sep;46(9):4516-21. Cancer Res. 1986. PMID: 2425956 - Laboratory and clinical studies of biochemical modulation by hydroxyurea.
Schilsky RL, Ratain MJ, Vokes EE, Vogelzang NJ, Anderson J, Peterson BA. Schilsky RL, et al. Semin Oncol. 1992 Jun;19(3 Suppl 9):84-9. Semin Oncol. 1992. PMID: 1641659 Review. - The nitric oxide producing reactions of hydroxyurea.
King SB. King SB. Curr Med Chem. 2003 Mar;10(6):437-52. doi: 10.2174/0929867033368213. Curr Med Chem. 2003. PMID: 12570692 Review.
Cited by
- VS411 reduced immune activation and HIV-1 RNA levels in 28 days: randomized proof-of-concept study for antiviral-hyperactivation limiting therapeutics.
Lori F, De Forni D, Katabira E, Baev D, Maserati R, Calarota SA, Cahn P, Testori M, Rakhmanova A, Stevens MR. Lori F, et al. PLoS One. 2012;7(10):e47485. doi: 10.1371/journal.pone.0047485. Epub 2012 Oct 19. PLoS One. 2012. PMID: 23094055 Free PMC article. Clinical Trial. - Polycythemia Vera: Barriers to and Strategies for Optimal Management.
Duminuco A, Harrington P, Harrison C, Curto-Garcia N. Duminuco A, et al. Blood Lymphat Cancer. 2023 Dec 21;13:77-90. doi: 10.2147/BLCTT.S409443. eCollection 2023. Blood Lymphat Cancer. 2023. PMID: 38146420 Free PMC article. Review. - New Therapeutic Options for the Treatment of Sickle Cell Disease.
Matte A, Zorzi F, Mazzi F, Federti E, Olivieri O, De Franceschi L. Matte A, et al. Mediterr J Hematol Infect Dis. 2019 Jan 1;11(1):e2019002. doi: 10.4084/MJHID.2019.002. eCollection 2019. Mediterr J Hematol Infect Dis. 2019. PMID: 30671208 Free PMC article. Review. - Identification of G1-regulated genes in normally cycling human cells.
Beyrouthy MJ, Alexander KE, Baldwin A, Whitfield ML, Bass HW, McGee D, Hurt MM. Beyrouthy MJ, et al. PLoS One. 2008;3(12):e3943. doi: 10.1371/journal.pone.0003943. Epub 2008 Dec 15. PLoS One. 2008. PMID: 19079774 Free PMC article. - E2F4 and ribonucleotide reductase mediate S-phase arrest in colon cancer cells treated with chlorophyllin.
Chimploy K, Díaz GD, Li Q, Carter O, Dashwood WM, Mathews CK, Williams DE, Bailey GS, Dashwood RH. Chimploy K, et al. Int J Cancer. 2009 Nov 1;125(9):2086-94. doi: 10.1002/ijc.24559. Int J Cancer. 2009. PMID: 19585502 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources